APO Research
Talk to an analyst

APO RESEARCH · REPORT

Prostaglandin

Prostaglandins are autocank derived from arachidonic acid. They both sustain homeostatic functions and mediate pathogenic mechanisms, including the inflammatory response. Prostaglandins control several processes in the body, especially as it relates to the healing process. When tissue is damaged or infected, this group of hormones will create the reactions that cause pain, fever and inflammation, which sparks the healing process. Prostaglandins also stimulate the formation of a blood clot and the contraction of the blood vessel wall when body is bleeding. Once blood clots are no longer needed and the injury begins to heal, another prostaglandin will stimulate the changes that allow the clots to dissipate and the blood vessel wall to relax.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Prostaglandins are autocank derived from arachidonic acid. They both sustain homeostatic functions and mediate pathogenic mechanisms, including the inflammatory response. Prostaglandins control several processes in the body, especially as it relates to the healing process. When tissue is damaged or infected, this group of hormones will create the reactions that cause pain, fever and inflammation, which sparks the healing process. Prostaglandins also stimulate the formation of a blood clot and the contraction of the blood vessel wall when body is bleeding. Once blood clots are no longer needed and the injury begins to heal, another prostaglandin will stimulate the changes that allow the clots to dissipate and the blood vessel wall to relax.

Selected research

Industry Growth & Trends

Global Prostaglandin Industry Growth and Trends Forecast to 2032

25 December 2025109 pages

Choose your research edition.

Industry ResearchProstaglandin Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Prostaglandin Industry Growth and Trends Forecast to 2032109 pages · $3,450 USDMarket StructureGlobal Prostaglandin Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Prostaglandin Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Prostaglandin Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

Prostaglandins are autocank derived from arachidonic acid. They both sustain homeostatic functions and mediate pathogenic mechanisms, including the inflammatory response. Prostaglandins control several processes in the body, especially as it relates to the healing process. When tissue is damaged or infected, this group of hormones will create the reactions that cause pain, fever and inflammation, which sparks the healing process. Prostaglandins also stimulate the formation of a blood clot and the contraction of the blood vessel wall when body is bleeding. Once blood clots are no longer needed and the injury begins to heal, another prostaglandin will stimulate the changes that allow the clots to dissipate and the blood vessel wall to relax.

Europe is the largest consumption place, with a consumption market share nearly 35% in 2019. Following Europe, North America is the second largest consumption place with the consumption market share of about 27%.

CEPIA, Johnson Matthey and Pfizer are the main manufacturers of prostaglandin, they take about 65% of the whole market.

Read the full market overview

Report Scope

This report provides a structured, data-driven view of the global Prostaglandin market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Prostaglandin market size, estimates, and forecasts are presented in terms of sales volume (Kg) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Prostaglandin market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Prostaglandin.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Prostaglandin market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Prostaglandin Market by Company

Sanofi CEPiA

Kyowa Hakko Pharma

Cayman Chemical

Yonsung Fine Chemicals

Johnson Matthey

Chirogate

Everlight Chemical

ANVI Pharma

AUSUN Pharmaceutical

Aspen Biopharma Labs

Prostaglandin Segment by Type

Human Prostaglandin

Veterinary Prostaglandin

Prostaglandin Segment by Application

Cardiovascular

Gynecological and Obstetrical

Ophthalmologic

Other

Prostaglandin Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Prostaglandin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Prostaglandin and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Prostaglandin.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Prostaglandin manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Prostaglandin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Human Prostaglandin Table 2. Major Company of Veterinary Prostaglandin Table 3. Global Prostaglandin Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Prostaglandin Sales by Type (2021-2026) & (Kg) Table 5. Global Prostaglandin Sales Market Share in Volume by Type (2021-2026) Table 6. Global Prostaglandin Sales by Type (2021-2026) & (US$ Million) Table 7. Global Prostaglandin Sales Market Share in Value by Type (2021-2026) Table 8. Global Prostaglandin Price by Type (2021-2026) & (USD/g) Table 9. Global Prostaglandin Sales by Type (2027-2032) & (Kg) Table 10. Global Prostaglandin Sales Market Share in Volume by Type (2027-2032) Table 11. Global Prostaglandin Sales by Type (2027-2032) & (US$ Million) Table 12. Global Prostaglandin Sales Market Share in Value by Type (2027-2032) Table 13. Global Prostaglandin Price by Type (2027-2032) & (USD/g) Table 14. North America Prostaglandin Sales by Type (2021-2026) & (Kg) Table 15. North America Prostaglandin Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Prostaglandin Sales by Type (2021-2026) & (Kg) Table 17. Europe Prostaglandin Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Prostaglandin Sales by Type (2021-2026) & (Kg) Table 19. Asia-Pacific Prostaglandin Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Prostaglandin Sales by Type (2021-2026) & (Kg) Table 21. Latin America Prostaglandin Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Prostaglandin Sales by Type (2021-2026) & (Kg) Table 23. Middle East and Africa Prostaglandin Sales by Type (2021-2026) & (US$ Million) Table 24. Prostaglandin Industry Trends Table 25. Prostaglandin Industry Drivers Table 26. Prostaglandin Industry Opportunities and Challenges Table 27. Prostaglandin Industry Restraints Table 28. Global Prostaglandin Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Prostaglandin Revenue Market Share by Company (2021-2026) Table 30. Global Prostaglandin Sales by Company (2021-2026) & (Kg) Table 31. Global Prostaglandin Sales Share by Company (2021-2026) Table 32. Global Prostaglandin Market Price by Company (2021-2026) & (USD/g) Table 33. Global Prostaglandin Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Prostaglandin Major Company Production Sites and Headquarters Table 35. Global Prostaglandin Company, Product Type & Application Table 36. Global Prostaglandin Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Prostaglandin by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Prostaglandin Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Prostaglandin Sales by Region (2021-2026) & (Kg) Table 41. Global Prostaglandin Sales Market Share in Volume by Region (2021-2026) Table 42. Global Prostaglandin Sales by Region (2021-2026) & (US$ Million) Table 43. Global Prostaglandin Sales Market Share in Value by Region (2021-2026) Table 44. Global Prostaglandin Sales (Kg), Value (US$ Million), Price (USD/g) and Gross Margin (2021-2026) Table 45. Global Prostaglandin Sales by Region (2027-2032) & (Kg) Table 46. Global Prostaglandin Sales Market Share in Volume by Region (2027-2032) Table 47. Global Prostaglandin Sales by Region (2027-2032) & (US$ Million) Table 48. Global Prostaglandin Sales Market Share in Value by Region (2027-2032) Table 49. Global Prostaglandin Sales (Kg), Value (US$ Million), Price (USD/g) and Gross Margin (2027-2032) Table 50. Global Prostaglandin Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Prostaglandin Sales by Application (2021-2026) & (Kg) Table 52. Global Prostaglandin Sales Market Share in Volume by Application (2021-2026) Table 53. Global Prostaglandin Sales by Application (2021-2026) & (US$ Million) Table 54. Global Prostaglandin Sales Market Share in Value by Application (2021-2026) Table 55. Global Prostaglandin Price by Application (2021-2026) & (USD/g) Table 56. Global Prostaglandin Sales by Application (2027-2032) & (Kg) Table 57. Global Prostaglandin Sales Market Share in Volume by Application (2027-2032) Table 58. Global Prostaglandin Sales by Application (2027-2032) & (US$ Million) Table 59. Global Prostaglandin Sales Market Share in Value by Application (2027-2032) Table 60. Global Prostaglandin Price by Application (2027-2032) & (USD/g) Table 61. North America Prostaglandin Sales by Application (2021-2026) & (Kg) Table 62. North America Prostaglandin Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Prostaglandin Sales by Application (2021-2026) & (Kg) Table 64. Europe Prostaglandin Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Prostaglandin Sales by Application (2021-2026) & (Kg) Table 66. Asia-Pacific Prostaglandin Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Prostaglandin Sales by Application (2021-2026) & (Kg) Table 68. Latin America Prostaglandin Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Prostaglandin Sales by Application (2021-2026) & (Kg) Table 70. Middle East and Africa Prostaglandin Sales by Application (2021-2026) & (US$ Million) Table 71. Sanofi CEPiA Company Information Table 72. Sanofi CEPiA Business Overview Table 73. Sanofi CEPiA Prostaglandin Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2021-2026) Table 74. Sanofi CEPiA Prostaglandin Product Portfolio Table 75. Sanofi CEPiA Recent Development Table 76. Kyowa Hakko Pharma Company Information Table 77. Kyowa Hakko Pharma Business Overview Table 78. Kyowa Hakko Pharma Prostaglandin Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2021-2026) Table 79. Kyowa Hakko Pharma Prostaglandin Product Portfolio Table 80. Kyowa Hakko Pharma Recent Development Table 81. Cayman Chemical Company Information Table 82. Cayman Chemical Business Overview Table 83. Cayman Chemical Prostaglandin Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2021-2026) Table 84. Cayman Chemical Prostaglandin Product Portfolio Table 85. Cayman Chemical Recent Development Table 86. Yonsung Fine Chemicals Company Information Table 87. Yonsung Fine Chemicals Business Overview Table 88. Yonsung Fine Chemicals Prostaglandin Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2021-2026) Table 89. Yonsung Fine Chemicals Prostaglandin Product Portfolio Table 90. Yonsung Fine Chemicals Recent Development Table 91. Johnson Matthey Company Information Table 92. Johnson Matthey Business Overview Table 93. Johnson Matthey Prostaglandin Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2021-2026) Table 94. Johnson Matthey Prostaglandin Product Portfolio Table 95. Johnson Matthey Recent Development Table 96. Chirogate Company Information Table 97. Chirogate Business Overview Table 98. Chirogate Prostaglandin Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2021-2026) Table 99. Chirogate Prostaglandin Product Portfolio Table 100. Chirogate Recent Development Table 101. Everlight Chemical Company Information Table 102. Everlight Chemical Business Overview Table 103. Everlight Chemical Prostaglandin Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2021-2026) Table 104. Everlight Chemical Prostaglandin Product Portfolio Table 105. Everlight Chemical Recent Development Table 106. ANVI Pharma Company Information Table 107. ANVI Pharma Business Overview Table 108. ANVI Pharma Prostaglandin Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2021-2026) Table 109. ANVI Pharma Prostaglandin Product Portfolio Table 110. ANVI Pharma Recent Development Table 111. AUSUN Pharmaceutical Company Information Table 112. AUSUN Pharmaceutical Business Overview Table 113. AUSUN Pharmaceutical Prostaglandin Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2021-2026) Table 114. AUSUN Pharmaceutical Prostaglandin Product Portfolio Table 115. AUSUN Pharmaceutical Recent Development Table 116. Aspen Biopharma Labs Company Information Table 117. Aspen Biopharma Labs Business Overview Table 118. Aspen Biopharma Labs Prostaglandin Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2021-2026) Table 119. Aspen Biopharma Labs Prostaglandin Product Portfolio Table 120. Aspen Biopharma Labs Recent Development Table 121. North America Prostaglandin Market Size Growth Rate (CAGR) by Country (Kg): 2021 VS 2025 VS 2032 Table 122. North America Prostaglandin Sales by Country (2021-2026) & (Kg) Table 123. North America Prostaglandin Sales Market Share by Country (2021-2026) Table 124. North America Prostaglandin Sales Forecast by Country (2027-2032) & (Kg) Table 125. North America Prostaglandin Sales Market Share Forecast by Country (2027-2032) Table 126. North America Prostaglandin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 127. North America Prostaglandin Market Size by Country (2021-2026) & (US$ Million) Table 128. North America Prostaglandin Market Share by Country (2021-2026) Table 129. North America Prostaglandin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 130. North America Prostaglandin Market Share Forecast by Country (2027-2032) Table 131. Europe Prostaglandin Market Size Growth Rate (CAGR) by Country (Kg): 2021 VS 2025 VS 2032 Table 132. Europe Prostaglandin Sales by Country (2021-2026) & (Kg) Table 133. Europe Prostaglandin Sales Market Share by Country (2021-2026) Table 134. Europe Prostaglandin Sales Forecast by Country (2027-2032) & (Kg) Table 135. Europe Prostaglandin Sales Market Share Forecast by Country (2027-2032) Table 136. Europe Prostaglandin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 137. Europe Prostaglandin Market Size by Country (2021-2026) & (US$ Million) Table 138. Europe Prostaglandin Market Share by Country (2021-2026) Table 139. Europe Prostaglandin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 140. Europe Prostaglandin Market Share Forecast by Country (2027-2032) Table 141. Asia-Pacific Prostaglandin Market Size Growth Rate (CAGR) by Country (Kg): 2021 VS 2025 VS 2032 Table 142. Asia-Pacific Prostaglandin Sales by Country (2021-2026) & (Kg) Table 143. Asia-Pacific Prostaglandin Sales Market Share by Country (2021-2026) Table 144. Asia-Pacific Prostaglandin Sales Forecast by Country (2027-2032) & (Kg) Table 145. Asia-Pacific Prostaglandin Sales Market Share Forecast by Country (2027-2032) Table 146. Asia-Pacific Prostaglandin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 147. Asia-Pacific Prostaglandin Market Size by Country (2021-2026) & (US$ Million) Table 148. Asia-Pacific Prostaglandin Market Share by Country (2021-2026) Table 149. Asia-Pacific Prostaglandin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 150. Asia-Pacific Prostaglandin Market Share Forecast by Country (2027-2032) Table 151. Latin America Prostaglandin Market Size Growth Rate (CAGR) by Country (Kg): 2021 VS 2025 VS 2032 Table 152. Latin America Prostaglandin Sales by Country (2021-2026) & (Kg) Table 153. Latin America Prostaglandin Sales Market Share by Country (2021-2026) Table 154. Latin America Prostaglandin Sales Forecast by Country (2027-2032) & (Kg) Table 155. Latin America Prostaglandin Sales Market Share Forecast by Country (2027-2032) Table 156. Latin America Prostaglandin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 157. Latin America Prostaglandin Market Size by Country (2021-2026) & (US$ Million) Table 158. Latin America Prostaglandin Market Share by Country (2021-2026) Table 159. Latin America Prostaglandin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 160. Latin America Prostaglandin Market Share Forecast by Country (2027-2032) Table 161. Middle East and Africa Prostaglandin Market Size Growth Rate (CAGR) by Country (Kg): 2021 VS 2025 VS 2032 Table 162. Middle East and Africa Prostaglandin Sales by Country (2021-2026) & (Kg) Table 163. Middle East and Africa Prostaglandin Sales Market Share by Country (2021-2026) Table 164. Middle East and Africa Prostaglandin Sales Forecast by Country (2027-2032) & (Kg) Table 165. Middle East and Africa Prostaglandin Sales Market Share Forecast by Country (2027-2032) Table 166. Middle East and Africa Prostaglandin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 167. Middle East and Africa Prostaglandin Market Size by Country (2021-2026) & (US$ Million) Table 168. Middle East and Africa Prostaglandin Market Share by Country (2021-2026) Table 169. Middle East and Africa Prostaglandin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 170. Middle East and Africa Prostaglandin Market Share Forecast by Country (2027-2032) Table 171. Key Raw Materials Table 172. Raw Materials Key Suppliers Table 173. Prostaglandin Distributors List Table 174. Prostaglandin Customers List Table 175. Research Programs/Design for This Report Table 176. Authors List of This Report Table 177. Secondary Sources Table 178. Primary Sources List of Figures Figure 1. Prostaglandin Image Figure 2. Global Prostaglandin Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Prostaglandin Market Size (2021-2032) & (US$ Million) Figure 4. Global Prostaglandin Sales (2021-2032) & (Kg) Figure 5. Human Prostaglandin Image Figure 6. Global Human Prostaglandin Sales YoY Growth (2021-2032) & (Kg) Figure 7. Veterinary Prostaglandin Image Figure 8. Global Veterinary Prostaglandin Sales YoY Growth (2021-2032) & (Kg) Figure 9. Global Prostaglandin Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Prostaglandin Market Share by Type 2025 VS 2032 Figure 11. North America Prostaglandin Sales Market Share in Volume by Type in 2025 Figure 12. North America Prostaglandin Sales Market Share in Value by Type in 2025 Figure 13. Europe Prostaglandin Sales Market Share in Volume by Type in 2025 Figure 14. Europe Prostaglandin Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Prostaglandin Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Prostaglandin Sales Market Share in Value by Type in 2025 Figure 17. Latin America Prostaglandin Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Prostaglandin Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Prostaglandin Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Prostaglandin Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Prostaglandin Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Cardiovascular Image Figure 24. Global Cardiovascular Sales YoY Growth (2021-2032) & (Kg) Figure 25. Gynecological and Obstetrical Image Figure 26. Global Gynecological and Obstetrical Sales YoY Growth (2021-2032) & (Kg) Figure 27. Ophthalmologic Image Figure 28. Global Ophthalmologic Sales YoY Growth (2021-2032) & (Kg) Figure 29. Other Image Figure 30. Global Other Sales YoY Growth (2021-2032) & (Kg) Figure 31. Global Prostaglandin Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Prostaglandin Market Share by Application 2025 VS 2032 Figure 33. North America Prostaglandin Sales Market Share in Volume by Application in 2025 Figure 34. North America Prostaglandin Sales Market Share in Value by Application in 2025 Figure 35. Europe Prostaglandin Sales Market Share in Volume by Application in 2025 Figure 36. Europe Prostaglandin Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Prostaglandin Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Prostaglandin Sales Market Share in Value by Application in 2025 Figure 39. Latin America Prostaglandin Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Prostaglandin Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Prostaglandin Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Prostaglandin Sales Market Share in Value by Application in 2025 Figure 43. North America Prostaglandin Sales by Country: 2021 VS 2025 VS 2032 (Kg) Figure 44. North America Prostaglandin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Prostaglandin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Prostaglandin Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Prostaglandin Sales by Country: 2021 VS 2025 VS 2032 (Kg) Figure 48. Europe Prostaglandin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Prostaglandin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Prostaglandin Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Prostaglandin Sales by Country: 2021 VS 2025 VS 2032 (Kg) Figure 52. Asia-Pacific Prostaglandin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Prostaglandin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Prostaglandin Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Prostaglandin Sales by Country: 2021 VS 2025 VS 2032 (Kg) Figure 56. Latin America Prostaglandin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Prostaglandin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Prostaglandin Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Prostaglandin Sales by Country: 2021 VS 2025 VS 2032 (Kg) Figure 60. Middle East and Africa Prostaglandin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Prostaglandin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Prostaglandin Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Prostaglandin Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Prostaglandin Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Human Prostaglandin
  • Veterinary Prostaglandin
Applications
  • Cardiovascular
  • Gynecological and Obstetrical
  • Ophthalmologic
  • Other
Companies covered
  • Sanofi CEPiA
  • Kyowa Hakko Pharma
  • Cayman Chemical
  • Yonsung Fine Chemicals
  • Johnson Matthey
  • Chirogate
  • Everlight Chemical
  • ANVI Pharma
  • AUSUN Pharmaceutical
  • Aspen Biopharma Labs

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Prostaglandin Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Prostaglandin Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Prostaglandin Market by Type
  6. 1.3.1 Human Prostaglandin
  7. 1.3.2 Veterinary Prostaglandin
  8. 1.4 Global Prostaglandin Market Size by Type
  9. 1.4.1 Global Prostaglandin Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Prostaglandin Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Prostaglandin Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Prostaglandin Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Prostaglandin Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Prostaglandin Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Prostaglandin Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Prostaglandin Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Prostaglandin Industry Trends
  2. 2.2 Prostaglandin Industry Drivers
  3. 2.3 Prostaglandin Industry Opportunities and Challenges
  4. 2.4 Prostaglandin Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Prostaglandin Revenue (2021-2026)
  2. 3.2 Global Top Players by Prostaglandin Sales (2021-2026)
  3. 3.3 Global Top Players by Prostaglandin Price (2021-2026)
  4. 3.4 Global Prostaglandin Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Prostaglandin Major Company Production Sites & Headquarters
  6. 3.6 Global Prostaglandin Company, Product Type & Application
  7. 3.7 Global Prostaglandin Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Prostaglandin Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Prostaglandin Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Prostaglandin Tier 1, Tier 2, and Tier 3
4 Prostaglandin Regional Status and Outlook
  1. 4.1 Global Prostaglandin Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Prostaglandin Historic Market Size by Region
  3. 4.2.1 Global Prostaglandin Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Prostaglandin Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Prostaglandin Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Prostaglandin Forecasted Market Size by Region
  7. 4.3.1 Global Prostaglandin Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Prostaglandin Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Prostaglandin Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Prostaglandin by Application
  1. 5.1 Prostaglandin Market by Application
  2. 5.1.1 Cardiovascular
  3. 5.1.2 Gynecological and Obstetrical
  4. 5.1.3 Ophthalmologic
  5. 5.1.4 Other
  6. 5.2 Global Prostaglandin Market Size by Application
  7. 5.2.1 Global Prostaglandin Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Prostaglandin Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Prostaglandin Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Prostaglandin Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Prostaglandin Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Prostaglandin Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Prostaglandin Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Prostaglandin Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Sanofi CEPiA
  2. 6.1.1 Sanofi CEPiA Company Information
  3. 6.1.2 Sanofi CEPiA Business Overview
  4. 6.1.3 Sanofi CEPiA Prostaglandin Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Sanofi CEPiA Prostaglandin Product Portfolio
  6. 6.1.5 Sanofi CEPiA Recent Developments
  7. 6.2 Kyowa Hakko Pharma
  8. 6.2.1 Kyowa Hakko Pharma Company Information
  9. 6.2.2 Kyowa Hakko Pharma Business Overview
  10. 6.2.3 Kyowa Hakko Pharma Prostaglandin Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Kyowa Hakko Pharma Prostaglandin Product Portfolio
  12. 6.2.5 Kyowa Hakko Pharma Recent Developments
  13. 6.3 Cayman Chemical
  14. 6.3.1 Cayman Chemical Company Information
  15. 6.3.2 Cayman Chemical Business Overview
  16. 6.3.3 Cayman Chemical Prostaglandin Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Cayman Chemical Prostaglandin Product Portfolio
  18. 6.3.5 Cayman Chemical Recent Developments
  19. 6.4 Yonsung Fine Chemicals
  20. 6.4.1 Yonsung Fine Chemicals Company Information
  21. 6.4.2 Yonsung Fine Chemicals Business Overview
  22. 6.4.3 Yonsung Fine Chemicals Prostaglandin Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Yonsung Fine Chemicals Prostaglandin Product Portfolio
  24. 6.4.5 Yonsung Fine Chemicals Recent Developments
  25. 6.5 Johnson Matthey
  26. 6.5.1 Johnson Matthey Company Information
  27. 6.5.2 Johnson Matthey Business Overview
  28. 6.5.3 Johnson Matthey Prostaglandin Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Johnson Matthey Prostaglandin Product Portfolio
  30. 6.5.5 Johnson Matthey Recent Developments
  31. 6.6 Chirogate
  32. 6.6.1 Chirogate Company Information
  33. 6.6.2 Chirogate Business Overview
  34. 6.6.3 Chirogate Prostaglandin Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Chirogate Prostaglandin Product Portfolio
  36. 6.6.5 Chirogate Recent Developments
  37. 6.7 Everlight Chemical
  38. 6.7.1 Everlight Chemical Company Information
  39. 6.7.2 Everlight Chemical Business Overview
  40. 6.7.3 Everlight Chemical Prostaglandin Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Everlight Chemical Prostaglandin Product Portfolio
  42. 6.7.5 Everlight Chemical Recent Developments
  43. 6.8 ANVI Pharma
  44. 6.8.1 ANVI Pharma Company Information
  45. 6.8.2 ANVI Pharma Business Overview
  46. 6.8.3 ANVI Pharma Prostaglandin Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 ANVI Pharma Prostaglandin Product Portfolio
  48. 6.8.5 ANVI Pharma Recent Developments
  49. 6.9 AUSUN Pharmaceutical
  50. 6.9.1 AUSUN Pharmaceutical Company Information
  51. 6.9.2 AUSUN Pharmaceutical Business Overview
  52. 6.9.3 AUSUN Pharmaceutical Prostaglandin Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 AUSUN Pharmaceutical Prostaglandin Product Portfolio
  54. 6.9.5 AUSUN Pharmaceutical Recent Developments
  55. 6.10 Aspen Biopharma Labs
  56. 6.10.1 Aspen Biopharma Labs Company Information
  57. 6.10.2 Aspen Biopharma Labs Business Overview
  58. 6.10.3 Aspen Biopharma Labs Prostaglandin Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Aspen Biopharma Labs Prostaglandin Product Portfolio
  60. 6.10.5 Aspen Biopharma Labs Recent Developments
7 North America by Country
  1. 7.1 North America Prostaglandin Sales by Country
  2. 7.1.1 North America Prostaglandin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Prostaglandin Sales by Country (2021-2026)
  4. 7.1.3 North America Prostaglandin Sales Forecast by Country (2027-2032)
  5. 7.2 North America Prostaglandin Market Size by Country
  6. 7.2.1 North America Prostaglandin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Prostaglandin Market Size by Country (2021-2026)
  8. 7.2.3 North America Prostaglandin Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Prostaglandin Sales by Country
  2. 8.1.1 Europe Prostaglandin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Prostaglandin Sales by Country (2021-2026)
  4. 8.1.3 Europe Prostaglandin Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Prostaglandin Market Size by Country
  6. 8.2.1 Europe Prostaglandin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Prostaglandin Market Size by Country (2021-2026)
  8. 8.2.3 Europe Prostaglandin Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Prostaglandin Sales by Country
  2. 9.1.1 Asia-Pacific Prostaglandin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Prostaglandin Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Prostaglandin Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Prostaglandin Market Size by Country
  6. 9.2.1 Asia-Pacific Prostaglandin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Prostaglandin Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Prostaglandin Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Prostaglandin Sales by Country
  2. 10.1.1 South America Prostaglandin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Prostaglandin Sales by Country (2021-2026)
  4. 10.1.3 South America Prostaglandin Sales Forecast by Country (2027-2032)
  5. 10.2 South America Prostaglandin Market Size by Country
  6. 10.2.1 South America Prostaglandin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Prostaglandin Market Size by Country (2021-2026)
  8. 10.2.3 South America Prostaglandin Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Prostaglandin Sales by Country
  2. 11.1.1 Middle East and Africa Prostaglandin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Prostaglandin Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Prostaglandin Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Prostaglandin Market Size by Country
  6. 11.2.1 Middle East and Africa Prostaglandin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Prostaglandin Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Prostaglandin Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Prostaglandin Value Chain Analysis
  2. 12.1.1 Prostaglandin Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Prostaglandin Production Mode & Process
  7. 12.2 Prostaglandin Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Prostaglandin Distributors
  10. 12.2.3 Prostaglandin Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst